Kevin Lin

Associate - Boston

Kevin Lin

Contact Information

Kevin Lin is an associate in Foley Hoag’s Business Department, working primarily in the Emerging Companies and Venture Capital Practice Group. Kevin’s practice focuses on working with emerging technology and life science companies throughout the corporate life cycle, including on early-stage formation and structuring matters, angel and venture financings, commercial transactions, mergers and acquisitions, and general corporate governance matters.

More »

Education:

  • Boston University School of Law, J.D., 2016
  • Cornell University, B.A., 2013

Languages:

English, Mandarin

Representative Experience

Venture Capital

  • Represented Zapata Computing, a quantum software company empowering enterprise teams to accelerate quantum solutions and capabilities, in closing its $38 million Series B financing, led by Comcast Ventures, Pitango and Prelude Ventures.
  • Represented fintech software company in its $25 million Series E financing. *
  • Represented healthcare venture capital fund in its $20 million Series A financing of a life sciences company. *
  • Represented biomanufacturing company in its $20 million Series A financing. *
  • Represented retail software analytics company in its $15 million Series C financing. *
  • Represented behavioral technology company in its $13 million Series C financing. *
  • Represented numerous venture capital firms in their portfolio investment activities.*

Mergers and Acquisitions

  • Represented global cannabis operator Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) in signing a definitive agreement to acquire Green Leaf Medical, LLC, a privately held, fully integrated cannabis multi-state operator based in the mid-Atlantic region, for approximately $240 million with the potential for additional performance-based milestone payments.
  • Represented NASDAQ-listed software company in its acquisition of a micro-app platform company for approximately $200 million. *
  • Represented private equity sponsor in its leveraged buyout of a manufacturing company. *
  • Represented telehealth company in its stock-for-stock merger with a competing telehealth company. *

*Prior to joining Foley Hoag

  • “Understanding the Chain of Liability Under HIPAA and How Business Associate Agreements Allocate Risk,” New Hampshire Bar News (January 2018)
  • Lead author, “Solo and Small Firm Cybersecurity Guide: Ethics and Data Security: What Are the Attorney’s Obligations,” New Hampshire Bar News (September 2017)
  • “Know the Law: Protect your company from cyber attacks,” New Hampshire Union Leader (March 2017)
  • Co-author, “Professional service companies face significant cyber risk,” New England In-House (February 2017); also published in New Hampshire Business Review (February 2017)
  • “Know the Law: Some data collecting requires disclosures,” New Hampshire Union Leader (December 2016)
  • Co-author, “Trends in M&A Provisions: Exclusion of Consequential Damages,” Mergers & Acquisitions Law Report, Bloomberg BNA (March 2014)
  • Lead author, “Basketball,” encyclopedia entry for Encyclopedia of Lying and Deception, SAGE Reference (March 2014)

Foley Hoag Alerts & Updates

Honors

  • Boston University Journal of Science and Technology Law, Note Editor

Involvement

  • Boston Bar Association
  • Massachusetts Bar Association
  • New Hampshire Bar Association
Add to Bio Folder

Download Bio

Bar Admissions

  • Massachusetts
  • New York
  • New Hampshire

Court Admissions

  • U.S. District Court for the District of New Hampshire